KCNE1L
KCNE1L, also known as KCNE5, is a gene that in humans encodes the KCNE5 protein. This protein is a member of the KCNE family, which consists of voltage-gated potassium channel accessory subunits. These subunits are essential for the modulation of potassium channel function, affecting the channels' gating properties, conductance, and ion selectivity. KCNE1L/KCNE5 specifically has been implicated in the modulation of cardiac and other tissue-specific potassium channels, playing a role in the physiological regulation of electrical activity in the heart and possibly other tissues.
Function[edit | edit source]
The KCNE family members are known to modulate the function of the Kv (voltage-gated potassium) channel complexes. KCNE1L, through its interaction with Kv channels, can alter the kinetics and voltage dependence of these channels. This modulation is crucial for the proper functioning of cardiac myocytes, influencing heart rate and rhythm. The exact mechanisms by which KCNE1L exerts its effects on potassium channels are complex and involve alterations in channel gating and ion selectivity. These interactions are vital for maintaining the electrical stability of cardiomyocytes, preventing arrhythmias, and ensuring the efficient contraction of the heart.
Clinical Significance[edit | edit source]
Alterations in the expression or function of KCNE1L can have significant clinical implications, particularly in the context of cardiac health. Mutations in the KCNE1L gene have been associated with various cardiac arrhythmias, including atrial fibrillation, one of the most common types of serious arrhythmia. These associations underscore the importance of KCNE1L in maintaining cardiac electrophysiological balance and highlight its potential as a target for therapeutic intervention in arrhythmia and other cardiac conditions.
Genetic and Molecular Biology[edit | edit source]
The KCNE1L gene is located on a specific chromosome region, and its product, the KCNE5 protein, is a small, single-transmembrane domain peptide. This protein co-assembles with the alpha subunits of potassium channels, such as Kv7.1 (encoded by the KCNQ1 gene), to form functional channel complexes. The interaction between KCNE1L and Kv7.1 is particularly important in the heart, where it contributes to the repolarization phase of the cardiac action potential, thereby influencing cardiac rhythm and rate.
Research Directions[edit | edit source]
Ongoing research is focused on elucidating the detailed mechanisms of KCNE1L interaction with potassium channels and its role in cardiac and possibly other physiological functions. Studies are also aimed at understanding the genetic variations within the KCNE1L gene and their associations with disease, with the goal of developing targeted therapies that can modulate KCNE1L function for the treatment of cardiac arrhythmias and other conditions.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD